Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Retrospective Evaluation of Ketamine Effectiveness for the Treatment of Acute Battlefield Related Pain

13 de agosto de 2019 actualizado por: Defense and Veterans Center for Integrative Pain Management

A Retrospective Evaluation of Ketamine Effectiveness for the Treatment of Acute Battlefield Related Pain

Using a retrospective review of records, we will conduct a multivariate analysis to examine the relationship between exposure to ketamine, as an analgesic agent in combat related trauma care, the use of additional opioid pain medications, and patient reported pain levels.

Descripción general del estudio

Estado

Terminado

Condiciones

Intervención / Tratamiento

Descripción detallada

This is a retrospective study to determine if there is a relationship between intravenous infusion of ketamine given for analgesia and the use of additional opioid pain medications and patient reported pain levels before and during ketamine usage. The investigator anticipates that records of up to 700 subjects will be reviewed for eligibility. The time period 24 hours before the initial ketamine therapy is initiated along with 24 & 48 hours after the start of ketamine therapy will be the time periods examined. The average/minimum/maximum pain scores during these time periods will be used. Medication usage will be calculated over the 24 hour time periods.

This protocol is presented as an initial step in exploring the possible relationship between the administration of ketamine as an analgesic agent, the potential reduction in pain medications, and the potential reduction of pain levels. With this the goals/objectives are as follows:

Objectives

  1. To compare morphine consumption in battlefield injured patients with acute pain 24 hours before the initiation of a ketamine infusion to the subsequent 48 hours following the start of infusion.
  2. To compare average/minimum/maximum pain scores in battlefield injured patients with acute pain 24 hours before the initiation of a ketamine infusion to the subsequent 48 hours following the start of infusion.
  3. To describe the pain trajectory in battlefield injured patients with acute pain after the initiation of ketamine infusions.
  4. To measure the absolute and proportional incidence of ketamine associated side effects in battlefield injured patients with acute pain following the initiation of ketamine infusions.

Tipo de estudio

De observación

Inscripción (Actual)

80

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

  • Estados Unidos
    • Maryland
      • Bethesda, Maryland, Estados Unidos, 20889
        • Walter Reed National Military Medical Center

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra de probabilidad

Población de estudio

Male and female military health care beneficiaries age 18 years and older

Descripción

Inclusion Criteria:

  • Battlefield injured from January 2007 to December 2013
  • Prescribed a ketamine infusion for acute pain
  • Awake, alert (non intubated/sedated), and able to report pain scores 24 hours prior to the start of infusion and up to 48 hours following infusion

Exclusion Criteria:

  • Patients who did not receive an injury in theater and did not receive ketamine while being treated by the APS or WRNMMC/WRAMC hospital staff
  • No continuous perineural catheter or epidural placement while on ketamine infusion
  • Less than 18 years old

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Battlefield Injury with ketamine treatment
Patients who received ketamine infusions to treat pain from January 2007 to December 2013.
Droga: ketamina

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Opioid consumption measured in morphine equivalents
Periodo de tiempo: 24 hours before ketamine infusion
Amount of opioids consumed within time frame
24 hours before ketamine infusion
Opioid consumption measured in morphine equivalents
Periodo de tiempo: 24 hours after ketamine infusion
Amount of opioids consumed within time frame
24 hours after ketamine infusion
Opioid consumption measured in morphine equivalents
Periodo de tiempo: 48 hours after ketamine infusion
Amount of opioids consumed within time frame
48 hours after ketamine infusion
Pain scores
Periodo de tiempo: 24 hours before ketamine infusion

Defense and Veterans Pain Rating Scale Pain scores recorded based on the Defense and Veterans Pain Rating Scale

Rate the severity of your CURRENT pain:

0 - No Pain

  1. - Hardly notice pain
  2. - Notice pain, does not interfere with activities
  3. - Sometimes distracts me
  4. - Distracts me, can do usual activities
  5. - Interrupts some activities
  6. - Hard to ignore, avoid usual activities
  7. - Focus of attention, prevents doing daily activities
  8. - Awful, hard to do anything
  9. - Can't bear pain, unable to do anything
  10. - As bad as it could be, nothing else matters

Circle the number that describes how, during the past 24 hours, pain has interfered with your usual activity:

0 - 10 (0=does not interfere, 10=completely interferes)

Circle the number that describes how, during the past 24 hours, pain has interfered with sleep:

0 - 10 (0=does not interfere, 10=completely interferes) Circle the number that describes how, during the past 24 hours, pain has affected your mood: 0-10
24 hours before ketamine infusion
Pain scores
Periodo de tiempo: 24 hours after ketamine infusion

Defense and Veterans Pain Rating Scale Pain scores recorded based on the Defense and Veterans Pain Rating Scale

Rate the severity of your CURRENT pain:

0 - No Pain

  1. - Hardly notice pain
  2. - Notice pain, does not interfere with activities
  3. - Sometimes distracts me
  4. - Distracts me, can do usual activities
  5. - Interrupts some activities
  6. - Hard to ignore, avoid usual activities
  7. - Focus of attention, prevents doing daily activities
  8. - Awful, hard to do anything
  9. - Can't bear pain, unable to do anything
  10. - As bad as it could be, nothing else matters

Circle the number that describes how, during the past 24 hours, pain has interfered with your usual activity:

0 - 10 (0=does not interfere, 10=completely interferes)

Circle the number that describes how, during the past 24 hours, pain has interfered with sleep:

0 - 10 (0=does not interfere, 10=completely interferes) Circle the number that describes how, during the past 24 hours, pain has affected your mood: 0-10
24 hours after ketamine infusion
Pain scores
Periodo de tiempo: 48 hours after ketamine infusion

Defense and Veterans Pain Rating Scale Pain scores recorded based on the Defense and Veterans Pain Rating Scale

Rate the severity of your CURRENT pain:

0 - No Pain

  1. - Hardly notice pain
  2. - Notice pain, does not interfere with activities
  3. - Sometimes distracts me
  4. - Distracts me, can do usual activities
  5. - Interrupts some activities
  6. - Hard to ignore, avoid usual activities
  7. - Focus of attention, prevents doing daily activities
  8. - Awful, hard to do anything
  9. - Can't bear pain, unable to do anything
  10. - As bad as it could be, nothing else matters

Circle the number that describes how, during the past 24 hours, pain has interfered with your usual activity:

0 - 10 (0=does not interfere, 10=completely interferes)

Circle the number that describes how, during the past 24 hours, pain has interfered with sleep:

0 - 10 (0=does not interfere, 10=completely interferes) Circle the number that describes how, during the past 24 hours, pain has affected your mood: 0-10
48 hours after ketamine infusion
Number of ketamine side effects
Periodo de tiempo: 24 hours before ketamine infusion
Recorded side effects after ketamine infusion
24 hours before ketamine infusion
Number of ketamine side effects
Periodo de tiempo: 24 after ketamine infusion
Recorded side effects after ketamine infusion
24 after ketamine infusion
Number of ketamine side effects
Periodo de tiempo: 48 hours after ketamine infusion
Recorded side effects after ketamine infusion
48 hours after ketamine infusion

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Defense and Veterans Center for Integrative Pain Management

Investigadores

  • Investigador principal: Michael Kent, MD, Walter Reed National Military Medical Center

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de agosto de 2014

Finalización primaria (Actual)

1 de agosto de 2017

Finalización del estudio (Actual)

30 de agosto de 2017

Fechas de registro del estudio

Enviado por primera vez

12 de agosto de 2019

Primero enviado que cumplió con los criterios de control de calidad

13 de agosto de 2019

Publicado por primera vez (Actual)

15 de agosto de 2019

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

15 de agosto de 2019

Última actualización enviada que cumplió con los criterios de control de calidad

13 de agosto de 2019

Última verificación

1 de agosto de 2019

Más información

Términos relacionados con este estudio

Palabras clave

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • 399623

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre ketamina

Buscar ensayos similares

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

CROs by country

CROs in France

Condiciones

Enfermedades Raras

Intervenciones de drogas

Suplementos dietéticos

Patrocinador / Colaboradores

Localizaciones

3
Suscribir